Two additional genes known primarily for their contribution to angiogenesis, VEGFR2 (KDR) and Ephrin A2 (EPHA2), were lowly expressed by the human cancer cells and did not change in response to aspirin treatment. This evidence concerns the gene EPHA2 and cancer.